Hydrophilic Catheter Coatings Market Global Report 2026

The hydrophilic catheter coatings market size has grown rapidly in recent years. It will grow from $0.84 billion in 2025 to $0.92 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period can be attributed to increasing adoption of minimally invasive procedures, rising demand for low-friction catheter surfaces, growing prevalence of catheter-based interventions, increasing emphasis on reducing procedure-related tissue trauma, and rising utilization of interventional medical devices.

The hydrophilic catheter coatings market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. Growth during the forecast period is anticipated to be driven by increasing demand for next-generation catheter coating technologies, greater adoption of advanced cardiovascular interventions, rising demand for biocompatible coating materials, growing development of complex catheter designs, and increasing focus on enhancing catheter navigation and procedural performance. Key trends during the forecast period include increasing development of low-friction hydrophilic coating formulations, greater adoption of durable and long-lasting catheter coatings, rising demand for uniform and defect-free coating applications, increasing development of lubricious coatings for complex anatomical pathways, and greater emphasis on improving coating adhesion and surface stability.

The growing adoption of minimally invasive and complex catheter-based procedures is expected to drive the growth of the hydrophilic catheter coatings market going forward. Minimally invasive and complex catheter-based procedures refer to medical interventions that use thin, flexible catheters inserted through small skin incisions or natural body openings to diagnose conditions, deliver therapies, or treat targeted anatomical sites. The adoption of these procedures is increasing because catheter-based interventions can reduce surgical trauma, shorten recovery periods, decrease hospital stays, and allow physicians to reach complex anatomical locations without performing open surgery. As the use of cardiovascular, neurovascular, peripheral vascular, electrophysiology, and other interventional procedures grows, demand is rising for catheters and guidewires that provide improved lubricity and maneuverability. Hydrophilic catheter coatings absorb and retain fluids on the device surface, lowering friction and enabling smooth movement through narrow, tortuous, and sensitive anatomical pathways, thereby improving procedural efficiency and patient comfort. For instance, in February 2025, according to Boston Scientific Corporation, a US-based medical device company, more than 200,000 patients globally had been treated using its FARAPULSE catheter-based pulsed field ablation system, compared with more than 40,000 patients reported in January 2024, representing approximately a fivefold increase in cumulative patients treated. Therefore, the growing adoption of minimally invasive and complex catheter-based procedures is driving the growth of the hydrophilic catheter coatings market.

Major companies operating in the hydrophilic catheter coatings market are focusing on developing ultraviolet (UV)-curable coating systems to improve catheter lubricity, coating durability, and manufacturing efficiency. UV-curable hydrophilic coatings form durable, water-attracting surfaces that lower friction and enable smoother movement of catheters and guidewires through blood vessels and other complex anatomical pathways. For instance, in May 2025, Hydromer Inc., a US-based medical device coatings company, introduced HydrUV, a UV-curable hydrophilic medical coating for medical devices, including cardiovascular and urological catheters and guidewires. The coating is designed to deliver long-lasting hydrophilicity, low friction, and improved durability, enabling smoother device navigation during minimally invasive procedures. Hydromer’s mechanical testing also demonstrated consistent coating performance over 50 cycles across various medical-device substrates. These developments allow catheter manufacturers to achieve low-friction surfaces with improved resistance to repeated mechanical stress while increasing coating-process efficiency, thereby supporting the production of more durable and dependable hydrophilic-coated catheters.

In November 2025, GTCR LLC, a US-based private equity firm, completed its acquisition of Surmodics Inc. for $627 million. The acquisition strengthened GTCR’s position in the hydrophilic coatings market and expanded its medical-device coatings portfolio alongside its existing investment in Biocoat, a major provider of outsourced hydrophilic coatings. Surmodics Inc. is a US-based medical device coatings company and a leading provider of hydrophilic coatings for medical devices, including catheters and guidewires.

Major companies operating in the hydrophilic catheter coatings market are dsm-firmenich AG, Freudenberg SE, Biocoat Inc., Precision Coating Company Inc., Specialty Coating Systems Inc., Harland Medical Systems Inc., Hydromer Inc., Surface Solutions Group LLC, AST Products Inc., Formacoat LLC, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Teleflex Incorporated.

North America was the dominating region in the hydrophilic catheter coatings market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the hydrophilic catheter coatings market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydrophilic catheter coatings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.